ESC Premium Access

Evolution of European Society of Cardiology Guidelines since 2000: a systematic appraisal

Topic: Primary cardiovascular prevention: interventions and outcomes

Congress Session

About the speaker

Doctor Charles Badu-Boateng

Frimley Park Hospital, Frimley (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

19 more presentations in this session

Nurse-led telephone-based follow-up of secondary prevention after acute myocardial infarction: one-year results from the randomized controlled NAILED-ACS trial.

Speaker: Doctor D. Huber (Umea, SE)


Six sigma approach to reduce door-to-balloon time for patients with ST-elevation myocardial infarction undergoing primary PCI

Speaker: Doctor T. Sharma (Baltimore, US)


Inhibition of acetylcholinesterase by bromide pyridostigmine prevents ventricular dysfunction, autonomic and reduce inflammatory profile in rats treated previously to myocardial infarction

Speaker: Ms C. Barboza (Sao Paulo, BR)


Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials

Speaker: Doctor D. Brie (Timisoara, RO)


The treatment benefit of the ACE-inhibitor perindopril on top of beta-blocker therapy in patients with vascular disease

Speaker: Doctor J. Brugts (Rotterdam, NL)


Access the full session

Poster session 2 - Cardiovascular prevention outcomes I

Speakers: Doctor C. Badu-Boateng, Doctor D. Huber, Doctor T. Sharma, Ms C. Barboza, Doctor D. Brie...

About the event



27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk